Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HPV-16/ 18”

77 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 77 results

Large-scale testing (Phase 3)Study completedNCT00092534
What this trial is testing

Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 12,167
Not applicableNot Yet RecruitingNCT07714577
What this trial is testing

Investigator-Initiated Study of BBM-C101 Injection in Subjects With HPV16/18 Infection

Who this might be right for
HPV16/18 Positive
Tianjin First Central Hospital 200
Not applicableStudy completedNCT01694875
What this trial is testing

Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System

Who this might be right for
Human Papillomavirus Infection
Gen-Probe, Incorporated 2,200
Testing effectiveness (Phase 2)UnknownNCT04800978
What this trial is testing

Combination of Durvalumab and BVAC-C in Patients With HPV 16 or 18 Positive Cervical Cancer Failure to First-Line Platinum-based Chemotherapy

Who this might be right for
Cervical Cancer
Samsung Medical Center 37
Large-scale testing (Phase 3)Study completedNCT00316706
What this trial is testing

Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine

Who this might be right for
Cervical Intraepithelial NeoplasiaPapillomavirus Infection
GlaxoSmithKline 1,245
Testing effectiveness (Phase 2)Study completedNCT00002916
What this trial is testing

Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer

Who this might be right for
Cervical Cancer
European Organisation for Research and Treatment of Cancer - EORTC 44
Early research (Phase 1)UnknownNCT03870113
What this trial is testing

DC Vaccines Targeting HPV16/18 E6/E7 Protein to Regress CINI/CIN2

Who this might be right for
Cervical Intraepithelial Neoplasia
Shenzhen People's Hospital 80
Post-approval studies (Phase 4)Looking for participantsNCT05334706
What this trial is testing

Assess the Reduction of Human Papillomavirus (HPV) Viral Infectivity and Transmission in HPV-Positive Women After Vaccination With 9vHPV (RIFT-HPV)

Who this might be right for
Cervical Intraepithelial Neoplasia Grade I/ II/ III (CIN I/II/III)Human Papillomavirus (HPV) InfectionsHigh-risk HPV+1 more
Miquel Angel Pavon Ribas 69
Large-scale testing (Phase 3)Study completedNCT00290277
What this trial is testing

Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline 300
Early research (Phase 1)Study completedNCT02379520
What this trial is testing

HPV-16/18 E6/E7-Specific T Lymphocytes, Relapsed HPV-Associated Cancers, HESTIA

Who this might be right for
Human Papillomavirus-Related CarcinomaHuman Papillomavirus Positive Oropharyngeal CarcinomaHuman Papillomavirus Positive Cervical Carcinoma+3 more
Baylor College of Medicine 32
Not applicableWithdrawnNCT01551537
What this trial is testing

Post-marketing Surveillance of GSK Biologicals' Cervarix™ When Administered to Healthy Females in Sri Lanka

Who this might be right for
Human Papillomavirus Infection
GlaxoSmithKline
Testing effectiveness (Phase 2)Active Not RecruitingNCT05280457
What this trial is testing

HPV 16-positive and/or HPV 18-positive Recurrent and/or For Patients With Metastatic Head and Neck Cancer to Evaluate GX-188E DNA Vaccination, GX-I7 and Nivolumab Combination Therapy

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Yonsei University 21
Not applicableNot Yet RecruitingNCT07606677
What this trial is testing

Peripheral Blood CyTOF Immune Model for Cervical Lesion Detection in HPV16/18+ Women

Who this might be right for
CIN 2/3Cervical Cancer (Early Detection)
Women's Hospital School Of Medicine Zhejiang University 1,465
Testing effectiveness (Phase 2)Study completedNCT02740777
What this trial is testing

Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females

Who this might be right for
Human PapillomavirusCervical Intraepithelial NeoplasiaPersistent Infection
Shanghai Zerun Biotechnology Co.,Ltd 900
Not applicableStudy completedNCT04064515
What this trial is testing

CTCs in Cervix Cancer

Who this might be right for
Cervical CancerHPV
NYU Langone Health 4
Large-scale testing (Phase 3)Study completedNCT00128661
What this trial is testing

Vaccine To Prevent Cervical Intraepithelial Neoplasia or Cervical Cancer in Younger Healthy Participants

Who this might be right for
Cervical CancerPrecancerous Condition
GlaxoSmithKline 7,466
Testing effectiveness (Phase 2)Study completedNCT01304524
What this trial is testing

VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3

Who this might be right for
Cervical Intraepithelial Neoplasia
Inovio Pharmaceuticals 167
Large-scale testing (Phase 3)Study completedNCT00294047
What this trial is testing

Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 5,752
Not applicableUnknownNCT04022148
What this trial is testing

The Prospective Cohort Study to Evaluate the Preventive Efficacy of HPV Vaccine in Japanese Women Aged 27-45 Years

Who this might be right for
Cancer of CervixVaccinia
University of Fukui 2,800
Large-scale testing (Phase 3)Study completedNCT02733068
What this trial is testing

A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.

Who this might be right for
Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Cervical Intraepithelial Neoplasia
Shanghai Zerun Biotechnology Co.,Ltd 12,000
Next Page